Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy. (Q40219504)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 10 October 2006

Language	Label	Description	Also known as
English	Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy.	scientific article published on 10 October 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Toshihiko Kuroda

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Samuel D Rabkin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Robert L Martuza

6

object named as

Robert L Martuza

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Tingguo Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Hiroshi Fukuhara

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Tomoki Todo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

1 reference

based on heuristic

inferred from title

publication date

10 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

789-797

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Oncolytic viral therapies - the clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Recent progress in the battle between oncolytic viruses and tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Endogenous inhibitors of angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Clinical translation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Platelet factor 4: an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Platelet factor 4 disrupts the intracellular signalling cascade induced by vascular endothelial growth factor by both KDR dependent and independent mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Fibroblast Growth Factor Messenger Ribonucleic Acid Expression in a Human Astrocytoma Cell Line: Regulation by Serum and Cell Density

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Elevated expression of basic fibroblast growth factor messenger ribonucleic acid in acoustic neuromas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Gene therapy strategies for tumor antiangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Cyclophosphamide allows for in vivo dose reduction of a potent oncolytic virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Mouse tumor model for neurofibromatosis type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.011

7 January 2021

Identifiers

10.1016/J.YMTHE.2006.07.011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17045531%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40219504&oldid=1620013021"